Cobitolimod

DB14819InvestigationalNucleic Acid Based Therapies

Cobitolimod is under investigation in clinical trial NCT03178669 (The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis).

Mechanism: Pharmacologically active on Toll-like receptor 9
Curator reviewed

Resolves to

Compound

UNII328101264RCAS1226822-98-5

Targets

Q9NR96TLR9

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Cobitolimod, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account